These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3350350)

  • 1. Accelerated repopulation in head and neck cancer.
    Withers HR; Maciejewski B; Taylor JM; Hliniak A
    Front Radiat Ther Oncol; 1988; 22():105-10. PubMed ID: 3350350
    [No Abstract]   [Full Text] [Related]  

  • 2. Evolution of the Radiation Therapy Oncology Group clinical trials for head and neck cancer.
    Fu KK; Cooper JS; Marcial VA; Laramore GE; Pajak TF; Jacobs J; Al-Sarraf M; Forastiere AA; Cox JD
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):425-38. PubMed ID: 8655364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of the radiosensitizer cisplatin. A pilot study].
    Klima A; Szepesi S
    Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):457-9. PubMed ID: 3683038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study.
    Lee DJ; Trotti A; Spencer S; Rostock R; Fisher C; von Roemeling R; Harvey E; Groves E
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):811-5. PubMed ID: 9845102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept].
    Dietz A; Rudat V; Nollert J; Flentje M; Maiei H; Wannenmacher M; Weidauer H
    Laryngorhinootologie; 1996 Dec; 75(12):745-53. PubMed ID: 9081280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.
    Wenz F; Lohr F; Flentje M; Rudat V; Dietz A; Wannenmacher M
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):771-6. PubMed ID: 9128950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reirradiation: exploring new territory in the therapy of recurrent head and neck cancer.
    Langer C; Damsker J; Ridge A
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):424-9, 440. PubMed ID: 16258428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Haas ML; Conley BA; Egorin MJ; Levy S; Sivasailam S; Herman JM; Jacobs MC; Gray WC; Ord RA; Aisner JA; Van Echo DA
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):49-56. PubMed ID: 10758304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemoradiotherapy for patients with advanced head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2049-57. PubMed ID: 9388513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional relapse after intensity-modulated radiotherapy for head-and-neck cancer.
    Duprez F; Bonte K; De Neve W; Boterberg T; De Gersem W; Madani I
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):450-8. PubMed ID: 20381266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24.
    Al-Sarraf M; Pajak TF; Byhardt RW; Beitler JJ; Salter MM; Cooper JS
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):777-82. PubMed ID: 9128951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer.
    Bucci MK; Rosenthal DI; Hershock D; Metz J; Devine P; Kligerman MM; Machtay M
    Am J Clin Oncol; 2004 Dec; 27(6):595-602. PubMed ID: 15577438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
    Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA
    Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated accelerated radiotherapy with concurrent carboplatin for locally advanced squamous cell carcinoma of the head and neck.
    Chan AK; Sanghera P; Choo BA; McConkey C; Mehanna H; Parmar S; Pracy P; Glaholm J; Hartley A
    Clin Oncol (R Coll Radiol); 2011 Feb; 23(1):34-9. PubMed ID: 20863676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27.
    Lee WR; Berkey B; Marcial V; Fu KK; Cooper JS; Vikram B; Coia LR; Rotman M; Ortiz H
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1069-75. PubMed ID: 9869231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant chemoradiation for head and neck cancer: saving lives or grays?
    Henk JM
    Clin Oncol (R Coll Radiol); 2001; 13(5):333-5. PubMed ID: 11716224
    [No Abstract]   [Full Text] [Related]  

  • 18. High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck.
    Regine WF; Valentino J; Arnold SM; Haydon RC; Sloan D; Kenady D; Strottmann J; Pulmano C; Mohiuddin M
    J Clin Oncol; 2001 Jul; 19(14):3333-9. PubMed ID: 11454880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxic Cell Radiosensitization in Head and Neck Squamous Cell Carcinoma: Running Out of Air.
    Morse RT; Mell LK
    Int J Radiat Oncol Biol Phys; 2024 Jul; 119(3):783-785. PubMed ID: 38851276
    [No Abstract]   [Full Text] [Related]  

  • 20. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
    Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.